oxazoles has been researched along with Cardiac Failure in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cosentino, F; Grobbee, DE; Lincoff, AM; Mellbin, L; Morici, N; Nozza, A; Perrone Filardi, P; Ponticelli, C; Savonitto, S; Schrieks, IC; Schwartz, GG; Stähli, BE; Tardif, JC | 1 |
| deTombe, PP; Mignery, GA; Sankar, N | 1 |
| Baader, M; Breitschopf, K; Falk, E; Gerl, M; Kramer, W; Linz, W; Rütten, H; Schäfer, HL; Wohlfart, P | 1 |
| Imaizumi, S; Miura, S; Saku, K; Uehara, Y; Yahiro, E | 1 |
| Buchhorn, R; Hulpke-Wette, M | 1 |
| Chen, K; Chen, SR; Cheng, H; Obayashi, M; Shimoni, Y; Ter Keurs, H; Walsh, MP; Xiao, B; Yang, D; Zhong, G | 1 |
| Block, A; Graves, T; Hauck, C; Katz, SD; LeJemtel, TH; Radin, M | 1 |
| Bousquet, P; Feldman, J | 1 |
| Callens-el Amrani, F; Paolaggi, F; Swynghedauw, B | 1 |
| Gurtner, HP | 1 |
3 review(s) available for oxazoles and Cardiac Failure
| Article | Year |
|---|---|
Chymase inhibitors.
Topics: Acetamides; Animals; Atrial Fibrillation; Azetidines; Benzoates; Cardiovascular Diseases; Chymases; Heart Failure; Humans; Hypertension; Mast Cells; Oxazoles; Pyrimidines; Quinazolines; Sulfonamides | 2013 |
BMS-193884 and BMS-207940 Bristol-Myers Squibb.
Topics: Animals; Clinical Trials as Topic; Drug Industry; Endothelin Receptor Antagonists; Heart Failure; Humans; Hypertension, Pulmonary; Oxazoles; Sulfonamides | 2002 |
Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection.
Topics: Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Failure; Humans; Hypertension; Imidazoles; Imidazoline Receptors; Oxazoles; Receptors, Drug; Rilmenidine | 1999 |
3 trial(s) available for oxazoles and Cardiac Failure
| Article | Year |
|---|---|
Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Aged; Albuminuria; Analysis of Variance; Biomarkers; Cause of Death; Comorbidity; Creatinine; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart Failure; Humans; Male; Oxazoles; Patient Discharge; Percutaneous Coronary Intervention; Peroxisome Proliferator-Activated Receptors; Predictive Value of Tests; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Factors; Thiophenes | 2017 |
Calcineurin-NFATc regulates type 2 inositol 1,4,5-trisphosphate receptor (InsP3R2) expression during cardiac remodeling.
Topics: Adult; Animals; Boron Compounds; Calcineurin; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Female; Heart Failure; Humans; Inositol 1,4,5-Trisphosphate Receptors; Macrocyclic Compounds; Male; Mice; Myocytes, Cardiac; NFATC Transcription Factors; Oxazoles; Promoter Regions, Genetic; Rats; Signal Transduction; Up-Regulation | 2014 |
Effect of aspirin and ifetroban on skeletal muscle blood flow in patients with congestive heart failure treated with Enalapril. Ifetroban Study Group.
Topics: Aged; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Interactions; Enalapril; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Muscle, Skeletal; Oxazoles; Platelet Aggregation Inhibitors; Plethysmography; Regional Blood Flow; Vasodilator Agents | 1999 |
5 other study(ies) available for oxazoles and Cardiac Failure
| Article | Year |
|---|---|
The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzoates; Biomarkers; Cardiotonic Agents; Cell Line; Disease Progression; Heart Failure; Hemodynamics; Humans; Hypoglycemic Agents; Male; Molecular Structure; Nitric Oxide Synthase Type III; Oxazoles; PPAR alpha; Ramipril; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rosiglitazone; Survival Rate; Thiazolidinediones | 2009 |
Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon beta-adrenergic stimulation in normal and failing hearts.
Topics: Adrenergic beta-Agonists; Animals; Arrhythmias, Cardiac; Benzylamines; Blotting, Western; Calcium Signaling; Carrier Proteins; Cell Line; Cyclic AMP-Dependent Protein Kinases; Heart Failure; Humans; Ion Channel Gating; Ion Transport; Isoproterenol; Kidney; Marine Toxins; Mice; Myocytes, Cardiac; Oxazoles; Peptide Fragments; Phosphoprotein Phosphatases; Phosphorylation; Phosphoserine; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Rabbits; Rats; Recombinant Fusion Proteins; Ryanodine Receptor Calcium Release Channel; Sodium-Calcium Exchanger; Staurosporine; Structure-Activity Relationship; Sulfonamides; Transfection | 2006 |
A bumpy road to breakthroughs. The news: it's hard to beat today's cardiac treatments.
Topics: Animals; Atherosclerosis; Coronary Thrombosis; Diabetes Mellitus, Type 2; Ethics, Clinical; Glycine; Heart Failure; Humans; Indoleacetic Acids; Myocardial Infarction; Oxazoles; Prostheses and Implants; Stroke; Treatment Failure; Ultrasonography | 2006 |
[The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats].
Topics: Animals; Antihypertensive Agents; Cardiomegaly; Collagen; Heart; Heart Failure; Hypertension; Nephrectomy; Oxazoles; Propranolol; Rats; Rats, Inbred Strains; Rilmenidine | 1989 |
Aminorex and pulmonary hypertension. A review.
Topics: Adult; Aminorex; Appetite Depressants; Carbon Dioxide; Cardiac Catheterization; Europe; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Oxazoles; Oxygen | 1985 |